Research progress in the determination methods of tumor markers

doi:10.3969/j.issn.1673-8640.2018.011.015

Abstract

Abstract:

Tumor is a serious hidden threat to human health,and the morbidity and mortality rates of the diseases caused by tumors are increasing year by year. Tumor markers are produced by tumor tissues or their host reacts,which can reflect and monitor the occurrence,development,prognosis and recurrence of tumors. Early determination of tumors is important,and monitoring the change of tumor markers is also an important method to evaluate the therapeutic effect of tumors. The common determination methods of tumor markers include immunology,biosensor,proteomics,molecular biology,liquid biopsy and so on. Different determination methods of tumor markers have different characteristics. This review focuses on the research progress of several common determination methods of tumor markers.

Key words: Tumor marker, Determination method, Proteomics

CLC Number:

R446.1

ZHANG Yingcong, ZHANG Ze, YU Hongwei, SANG Zhuoqi, CHANG Dong. Research progress in the determination methods of tumor markers[J]. Laboratory Medicine, 2018, 33(11): 1036-1042.

References 53

[1]	GERDTSSON A S, WINGREN C, PERSSON H, et al.Plasma protein profiling in a stage defined pancreatic cancer cohort-implications for early diagnosis[J]. Mol Oncol, 2016, 10(8):1305-1316.
[2]	COLEMAN R L, HERZOG T J, CHAN D W, et al. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses[J]. Am J Obstet Gynecol,2016,215(1):82e1-82.e11.
[3]	MURATA T, TSUZAKI K, NIRENGI S, et al.Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: comparison between radioimmunoassay and enzyme-linked immunosorbent assay[J]. J Diabetes Investig, 2017, 8(4):475-479.
[4]	CHANG Y, XU J, ZHANG Q.Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer[J]. Oncol Lett, 2017, 14(4):4043-4052.
[5]	NAKAGAWA M, KARASHIMA T, KAMADA M, et al.Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer[J]. Biomark Res, 2017, 5:29.
[6]	ZHAO L, DAN W, SHI G, et al.Dual-labeled chemiluminescence enzyme immunoassay for simultaneous measurement of total prostate specific antigen (TPSA) and free prostate specific antigen (FPSA)[J]. Luminescence, 2017,32(8):1547-1553.
[7]	LIU J, ZHAO J, LI S, et al.A novel microchip electrophoresis-based chemiluminescence immunoassay for the detection of alpha-fetoprotein in human serum[J]. Talanta, 2017, 165:107-111.
[8]	LI S, YANG T, ZHAO J, et al.Chemiluminescence noncompetitive immunoassay based on microchip electrophoresis for the determination of β-subunit of human chorionic gonadotropin[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2017, 1053:42-47.
[9]	ZHANG Q, DAI H, WANG T, et al.Ratiometric electrochemiluminescent immunoassay for tumor marker regulated by mesocrystals and biomimetic catalyst[J]. Electrochimica Acta, 2016, 196:565-571.
[10]	LI S, SHI M, ZHAO J, et al.A highly sensitive capillary electrophoresis immunoassay strategy based on dual-labeled gold nanoparticles enhancing chemiluminescence for the detection of prostate-specific antigen[J]. Electrophoresis, 2017, 38(13-14):1780-1787.
[11]	HUANG Z J, HAN W D, WU Y H, et al.Magnetic electrochemiluminescent immunoassay with quantum dots label for highly efficient detection of the tumor marker α-fetoprotein[J]. J Electroanal Chem, 2017, 785:8-13.
[12]	GUO Z, HAO T, DU S, et al.Multiplex electrochemiluminescence immunoassay of two tumor markers using multicolor quantum dots as labels and graphene as conducting bridge[J]. Biosens Bioelectron, 2013, 44:101-107.
[13]	SHIM C, CHONG R, LEE J H.Enzyme-free chemiluminescence immunoassay for the determination of thyroid stimulating hormone[J]. Talanta, 2017, 171:229-235.
[14]	ZHANG M, GE S, LI W, et al.Ultrasensitive electrochemiluminescence immunoassay for tumor marker detection using functionalized Ru-silica@nanoporous gold composite as labels[J]. Analyst, 2012, 137(3):680-685.
[15]	BABAMIRI B, HALLAJ R, SALIMI A.Ultrasensitive electrochemiluminescence immunoassay for simultaneous determination of CA125 and CA15-3 tumor markers based on PAMAM-sulfanilic acid-Ru(bpy)32+ and PAMAM-CdTe@CdS nanocomposite[J]. Biosens Bioelectron, 2018, 99:353-360.
[16]	YANG Z, CAO Y, LI J, et al.Smart CuS nanoparticles as peroxidase mimetics for the design of novel label-free chemiluminescent immunoassay[J]. ACS Appl Mater Interfaces, 2016, 8(19):12031-12038.
[17]	CHEN S L,LI Y L,TANG Y, et al.Development and evaluation of a double antibody sandwich ELISA for the detection of human sDC-SIGN[J]. J Immunological Methods, 2016, 436:16-21.
[18]	YAMASHITA J, KOBAYASHI I, TATEMATSU K, et al.Sandwich ELISA using a mouse/human chimeric CSLEX-1 antibody[J]. Clin Chem,2016, 62(11):1516-1523.
[19]	OUJI-SAGESHIMA N, GERAGHTY D E, ISHITANI A, et al.Establishment of optimized ELISA system specific for HLA-G in body fluids[J]. HLA, 2016, 88(6):293-299.
[20]	LI Y, LI Y, ZHAO J, et al.Development of a sensitive luciferase-based sandwich ELISA system for the detection of human extracellular matrix 1 protein[J]. Monoclon Antib Immunodiagn Immunother, 2016, 35(6):273-279.
[21]	LAKSHMIPRIYA T, GOPINATH S C B, HASHIM U, et al. Multi-analyte validation in heterogeneous solution by ELISA[J]. Int J Biol Macromol, 2017,105(Pt 1):796-800.
[22]	WANG J, CAO Y, XU Y, et al.Colorimetric multiplexed immunoassay for sequential detection of tumor markers[J]. Biosens Bioelectron, 2009, 25(2):532-536.
[23]	ZHANG B, WANG X, ZHAO Y, et al.Highly photosensitive colorimetric immunoassay for tumor marker detection based on Cu2+ doped Ag-AgI nanocomposite[J]. Talanta, 2017, 167:111-117.
[24]	LAI G, WANG L, WU J, et al.Electrochemical stripping analysis of nanogold label-induced silver deposition for ultrasensitive multiplexed detection of tumor markers[J]. Anal Chim Acta, 2012, 721:1-6.
[25]	LIANG Y H, CHANG C C, CHEN C C, et al.Development of an Au/ZnO thin film surface plasmon resonance-based biosensor immunoassay for the detection of carbohydrate antigen 15-3 in human saliva[J]. Clin Biochem,2012,45(18):1689-1693.
[26]	LIU N, FENG F, LIU Z, et al.Porous platinum nanoparticles and PdPt nanocages for use in an ultrasensitive immunoelectrode for the simultaneous determination of the tumor markers CEA and AFP[J]. Microchim Acta, 2015, 182(5-6):1143-1151.
[27]	ZHANG X, ZHOU D, SHENG S, et al.Electrochemical immunoassay for the cancer marker LMP-1 (Epstein-Barr virus-derived latent membrane protein 1) using a glassy carbon electrode modified with Pd@Pt nanoparticles and a nanocomposite consisting of graphene sheets and MWCNTs[J]. Microchim Acta, 2016, 183(6):1-8.
[28]	LIANG M, YUAN R, CHAI Y, et al.Double layer enzyme modified carbon nanotubes as label for sandwich-type immunoassay of tumor markers[J]. Microchim Acta, 2011, 172(3-4):373-378.
[29]	LIU Z, RONG Q, MA Z, et al.One-step synthesis of redox-active polymer/AU nanocomposites for electrochemical immunoassay of multiplexed tumor markers[J]. Biosens Bioelectron, 2015, 65:307-313.
[30]	CAI X, WENG S, GUO R, et al.Ratiometric electrochemical immunoassay based on internal reference value for reproducible and sensitive detection of tumor marker[J]. Biosens Bioelectron, 2016, 81:173-180.
[31]	TANG Z, MA Z.Ultrasensitive amperometric immunoassay for carcinoembryonic antigens by using a glassy carbon electrode coated with a polydopamine-Pb(Ⅱ) redox system and a chitosan-gold nanocomposite[J]. Microchim Acta, 2017:1-8.
[32]	LIU W, ZHANG A, XU G, et al.Manganese modified CdTe/CdS quantum dots as an immunoassay biosensor for the detection of Golgi protein-73[J]. J Pharm Biomed Anal, 2015, 117:18-25.
[33]	TIAN J, ZHOU L, ZHAO Y, et al.Multiplexed detection of tumor markers with multicolor quantum dots based on fluorescence polarization immunoassay[J]. Talanta, 2012, 92:72-77.
[34]	SUN X C, LEI C, GUO L, et al.Giant magneto-resistance based immunoassay for the tumor marker carcinoembryonic antigen[J]. Microchim Acta, 2016, 183(3):1107-1114.
[35]	WANG H, MA Z.A cascade reaction signal-amplified amperometric immunosensor platform for ultrasensitive detection of tumor marker[J]. Sensors Actuators B Chemical, 2017,2017: 254.
[36]	HUANG Y, TANG C, LIU J, et al.Signal amplification strategy for electrochemical immunosensing based on a molybdophosphate induced enhanced redox current on the surface of hydroxyapatite nanoparticles[J]. Microchim Acta, 2017, 184(3):1-7.
[37]	HODGKINSON V C, AGARWAL V, ELFADL D, et al.Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer[J]. J Proteomics, 2012, 75(9):2745-2752.
[38]	CHEN Y T, CHEN H W, DOMANSKI D, et al.Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers[J]. J Proteomics, 2012, 75(12):3529-3545.
[39]	SINCLAIR J, TIMMS J F.Ovarian cancer[M]. Clifton:Humana Press, 2013:271.
[40]	WANG F, XIE B, WANG B, et al.LC-MS/MS glycomic analyses of free and conjugated forms of the sialic acids, Neu5Ac, Neu5Gc and KDN in human throat cancers[J]. Glycobiology, 2015, 25(12):1362-1374.
[41]	SONNTAG J, BENDER C, SOONS Z, et al.Reverse phase protein array based tumor profiling identifies a biomarker signature for risk classification of hormone receptor-positive breast cancer[J]. Translational Proteomics, 2014, 2(1):52-59.
[42]	DUAN L, WANG Y, LI S S, et al.Rapid and simultaneous detection of human hepatitis B virus and hepatitis C virus antibodies based on a protein chip assay using nano-gold immunological amplification and silver staining method[J]. BMC Infect Dis, 2005, 5:53.
[43]	YANG Z X, CHEN B A, WANG H, et al.Handy, rapid and multiplex detection of tumor markers based on encoded silica-hydrogel hybrid beads array chip[J]. Biosens Bioelectron, 2013, 48:153-157.
[44]	JIN X L,XU B,WU Y L.Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology[J]. World J Gastroenterol, 2014, 20(40):14958-14964.
[45]	GAO G, CHERNOCK R D, GAY H A, et al.A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis[J]. Int J Cancer, 2013, 132(4):882-890.
[46]	YADEGARAZARI R, HASSANZADEH T, MAJLESI A, et al.Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study[J]. Iran Biomed J, 2013, 17(1):15-21.
[47]	VAN NESTE L, BIGLEY J, TOLL A, et al.A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection[J]. BMC Urol, 2012, 12:16.
[48]	LIN Q, MAO W, SHU Y, et al.A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR[J]. J Cancer Res Clin Oncol, 2012, 138(1):85-93.
[49]	GONZALGO M L, NAKAYAMA M, LEE S M, et al.Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis[J]. Urology, 2004, 63(2):414-418.
[50]	KOIKE H, ICHIKAWA D, IKOMA H, et al.Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients[J]. J Surg Oncol, 2004, 87(4):182-186.
[51]	LV Y, MU N, MA C, et al.Detection value of tumor cells in cerebrospinal fluid in the diagnosis of meningeal metastasis from lung cancer by immuno-FISH technology[J]. Oncol Lett, 2016, 12(6):5080-5084.
[52]	TINAWI-ALJUNDI R, KNUTH S T, GILDEA M, et al.Minimally invasive prostate cancer detection test using FISH probes[J]. Res Rep Urol, 2016, 8:105-111.
[53]	FERNÁNDEZ-SERRA A, RUBIO L, CALATRAVA A, et al. Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR[J]. Biomed Res Int,2013,2013(3):465179.